title: Management of Ulcerative Colitis Using Vedolizumab After Liver Transplantation for Primary Sclerosing Cholangitis.
authors.affiliation: Unité de Transplantation Hépatique, Pôle Digestif, CHU Saint-Eloi, Montpellier, France m-meszaros@chu-montpellier.fr.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Meszaros
authors.affiliation: Unité de Transplantation Hépatique, Pôle Digestif, CHU Saint-Eloi, Montpellier, France Département de transplantation hépatique, Université Montpellier I, Montpellier, France.
authors.forename: Georges-Philippe
authors.initials: GP
authors.lastname: Pageaux
authors.affiliation: Unité de Transplantation Hépatique, Pôle Digestif, CHU Saint-Eloi, Montpellier, France Département de transplantation hépatique, Université Montpellier I, Montpellier, France.
authors.forename: Romain
authors.initials: R
authors.lastname: Altwegg
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000601:surgery*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D012074:Remission Induction
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; C543529:vedolizumab